Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma
V Vandecaveye, P Dirix, F De Keyzer… - International Journal of …, 2012 - Elsevier
PURPOSE: To evaluate diffusion-weighted imaging (DWI) for assessment of treatment
response in head and neck squamous cell carcinoma (HNSCC) three weeks after the end of
chemoradiotherapy (CRT). METHODS AND MATERIALS: Twenty-nine patients with HNSCC
underwent magnetic resonance imaging (MRI) prior to and 3 weeks after CRT, including T2-
weighted and pre-and postcontrast T1-weighted sequences and an echo-planar DWI
sequence with six b values (0 to 1,000 s/mm2), from which the apparent diffusion coefficient …
response in head and neck squamous cell carcinoma (HNSCC) three weeks after the end of
chemoradiotherapy (CRT). METHODS AND MATERIALS: Twenty-nine patients with HNSCC
underwent magnetic resonance imaging (MRI) prior to and 3 weeks after CRT, including T2-
weighted and pre-and postcontrast T1-weighted sequences and an echo-planar DWI
sequence with six b values (0 to 1,000 s/mm2), from which the apparent diffusion coefficient …
以上显示的是最相近的搜索结果。 查看全部搜索结果